These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 28624694)
21. [High-dose chemotherapy with stem cell support for solid tumors in adults]. Rodenhuis S; de Vries EG Ned Tijdschr Geneeskd; 1999 Apr; 143(14):731-8. PubMed ID: 10347628 [TBL] [Abstract][Full Text] [Related]
22. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review]. Cheng YC; Ueno NT Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734 [TBL] [Abstract][Full Text] [Related]
24. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancer. Soria JC; Adjei AA; Bahleda R; Besse B; Ferte C; Planchard D; Zhou J; Ware J; Morrissey K; Shankar G; Lin W; Schutzman JL; Dy GK; Groen HJM Eur J Cancer; 2017 Nov; 86():186-196. PubMed ID: 28992562 [TBL] [Abstract][Full Text] [Related]
25. The role of stem cell transplantation in the management of chronic lymphocytic leukaemia. Tam CS; Khouri I Hematol Oncol; 2009 Jun; 27(2):53-60. PubMed ID: 19358149 [TBL] [Abstract][Full Text] [Related]
26. Perspective: haematopoietic stem cell rescue enabling high-dose chemotherapy, tool for immunotherapy. Storb R Dev Biol (Basel); 2002; 108():123-6. PubMed ID: 12220135 [No Abstract] [Full Text] [Related]
27. Haematopoietic stem cell transplant activity in Switzerland 1997/1998: a report by the STABMT. Swisstransplant Working Group Blood and Marrow Transplantation. Schweiz Med Wochenschr; 2000 Jul; 130(27-28):1027-33. PubMed ID: 10953852 [TBL] [Abstract][Full Text] [Related]
28. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036 [TBL] [Abstract][Full Text] [Related]
29. Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT. Ringdén O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M; Br J Haematol; 2017 Feb; 176(3):431-439. PubMed ID: 27879990 [TBL] [Abstract][Full Text] [Related]
30. A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation. Grüllich C; Bertz H; Spyridonidis A; Müller CI; Finke J Bone Marrow Transplant; 2008 May; 41(10):845-50. PubMed ID: 18209719 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies in conditioning regimens for hematopoietic cell transplantation. Kharfan-Dabaja MA; Nishihori T; Otrock ZK; Haidar N; Mohty M; Hamadani M Biol Blood Marrow Transplant; 2013 Sep; 19(9):1288-300. PubMed ID: 23618718 [TBL] [Abstract][Full Text] [Related]
32. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Williams SF; Bitran JD; Richards JM; DeChristopher PJ; Orlina AR Prog Clin Biol Res; 1990; 333():461-9. PubMed ID: 1968650 [No Abstract] [Full Text] [Related]
33. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766 [TBL] [Abstract][Full Text] [Related]
35. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related]
36. Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation. Lim ZY; Cook G; Johnson PR; Parker A; Zuckerman M; Marks D; Wiltshire H; Mufti GJ; Pagliuca A Leuk Res; 2009 Feb; 33(2):244-9. PubMed ID: 18805583 [TBL] [Abstract][Full Text] [Related]